- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Interventional
- Objective: To determine the usefulness of pregabalin in treatment of the post-COVID chronic fatigue syndrome
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from to
- Study includes follow-up for 6 months
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Pregabalin
External Links
Other information
Funders/Sponsors:
- National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to